BHCM
ELV icon

Brevan Howard Capital Management’s Elevance Health ELV Stock Holding History

Brevan Howard Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.15M Sell
15,904
-824
-5% -$306K 0.05% 279
2026
Q1 		$4.9M Buy
+16,728
New +$5.5M 0.04% 235
2025
Q4 		– Sell
-11,874
Closed -$3.84M – 1926
2025
Q3 		$3.84M Sell
11,874
-23,597
-67% -$7.34M 0.02% 310
2025
Q2 		$13.8M Buy
+35,471
New +$14.3M 0.08% 128
2025
Q1 		– Sell
-5,548
Closed -$2.05M – 1243
2024
Q4 		$2.05M Buy
5,548
+2,568
+86% +$1.07M 0.01% 280
2024
Q3 		$1.55M Sell
2,980
-7,485
-72% -$4M 0.01% 324
2024
Q2 		$5.67M Buy
10,465
+7,514
+255% +$3.97M 0.05% 84
2024
Q1 		$1.53M Buy
2,951
+2,181
+283% +$1.08M 0.01% 187
2023
Q4 		$363K Buy
+770
New +$356K ﹤0.01% 631

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brevan Howard Capital Management's ELV Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Elevance Health (ELV) stake by 4.9% in Q2 2026, selling an estimated $306K and leaving 15,904 shares worth $6.15M. The position accounts for 0.05% of the portfolio, ranked #279.

Brevan Howard Capital Management first reported a position in ELV in Q4 2023 and has held it in 9 quarters since. The position peaked at $13.8M in Q2 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Brevan Howard Capital Management held 15,904 shares of Elevance Health worth $6.15M as of Q2 2026.
  • Brevan Howard Capital Management sold 824 Elevance Health shares in Q2 2026, an estimated $306K.
  • Elevance Health made up 0.05% of Brevan Howard Capital Management's portfolio in Q2 2026, its #279 holding.
  • Brevan Howard Capital Management first reported a position in Elevance Health in Q4 2023 and has held it in 9 quarters since.
  • Brevan Howard Capital Management's Elevance Health position peaked at $13.8M in Q2 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.